SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-001164
Filing Date
2019-03-13
Accepted
2019-03-13 08:41:13
Documents
5
Period of Report
2019-04-24
Effectiveness Date
2019-03-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238030zdef14a.htm DEF 14A 505988
2 G1041368.JPG g1041368.jpg GRAPHIC 7520
3 G1015754.JPG g1015754.jpg GRAPHIC 8834
4 G24502BII001.GIF g24502bii001.gif GRAPHIC 95268
5 G24502BII002.GIF g24502bii002.gif GRAPHIC 72488
  Complete submission text file 0001047469-19-001164.txt   761298
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 19677180
SIC: 2834 Pharmaceutical Preparations